S100A8 and neoplasm: The reduction in neutrophil infiltration by zotatifin was also confirmed by immunostaining for the neutrophil marker S100A8 in 2153L, 2225L-LM2, and 2208L tumor tissues (Figure 2C and Supplemental Figure 2, A and B).